Periotherapia Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
14
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$6.82M
- Investors
-
9
Periotherapia General Information
Description
Developer of antibody therapies designed to target pathological periostin for intractable diseases. The company offers pathological periostin neutralizing antibodies, metastatic breast cancer therapies, recurrent breast cancer treatments, diagnostic agents, antibody drug candidates, and clinical trial pharmaceuticals, enabling medical institutions to treat resistant cancers and inflammatory diseases through selective splicing variant targeting and academic research integration.
Contact Information
Website
www.periotherapia.co.jpCorporate Office
- 2-12-11 Nishinakajima
- Yodogawa-ku
- Osaka, 532-0011
- Japan
Corporate Office
- 2-12-11 Nishinakajima
- Yodogawa-ku
- Osaka, 532-0011
- Japan
Periotherapia Timeline
Periotherapia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Grant | 02-Jun-2026 | $6.82M | Completed | Generating Revenue | ||
| 7. Later Stage VC (Series D2) | 26-May-2026 | Completed | Generating Revenue | |||
| 6. Later Stage VC (Series D) | 31-Jan-2025 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | 09-Mar-2022 | Completed | Generating Revenue | |||
| 4. Early Stage VC (Series B) | 01-Sep-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 05-Apr-2019 | Completed | Generating Revenue | |||
| 2. Seed Round | 13-Dec-2017 | $622K | $622K | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Periotherapia Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Class D | ||||||||
| Class D1 | ||||||||
| Class C1 | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A | 3,572 | $446.76 | $446.76 | 1x | $446.76 | 12.52% | ||
| Series A-1 | 2,000 | $223.38 | $223.38 | 1x | $223.38 | 7.01% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Periotherapia Patents
Periotherapia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2022406341-A1 | Antibody or antigen-binding fragment thereof | Pending | 07-Dec-2021 | ||
| CA-3242041-A1 | Antibody or antigen-binding fragment thereof | Pending | 07-Dec-2021 | ||
| EP-4446343-A1 | Antibody or antigen-binding fragment thereof | Pending | 07-Dec-2021 | ||
| JP-2023084565-A | Antibody or antigen-binding fragment thereof | Active | 07-Dec-2021 | ||
| JP-2023084671-A | Antibody or antigen-binding fragment thereof | Active | 07-Dec-2021 | C07K16/18 |
Periotherapia Signals
Periotherapia Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Japan Agency for Medical Research and Development | Government | |||
| Techno Science | Venture Capital | Minority | ||
| Chishima Land | Corporation | Minority | ||
| Chishima Real Estate | Real Estate | Minority | ||
| Chushin Venture Capital | Corporate Venture Capital | Minority |
Periotherapia FAQs
-
When was Periotherapia founded?
Periotherapia was founded in 2017.
-
Where is Periotherapia headquartered?
Periotherapia is headquartered in Osaka, Japan.
-
What is the size of Periotherapia?
Periotherapia has 14 total employees.
-
What industry is Periotherapia in?
Periotherapia’s primary industry is Drug Discovery.
-
Is Periotherapia a private or public company?
Periotherapia is a Private company.
-
What is Periotherapia’s current revenue?
The current revenue for Periotherapia is .
-
How much funding has Periotherapia raised over time?
Periotherapia has raised $18.5M.
-
Who are Periotherapia’s investors?
Japan Agency for Medical Research and Development, Techno Science, Chishima Land, Chishima Real Estate, and Chushin Venture Capital are 5 of 9 investors who have invested in Periotherapia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process